Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

15.17
+1.138.05%
Pre-market: 15.490.3240+2.14%04:00 EDT
Volume:7.74M
Turnover:116.71M
Market Cap:2.09B
PE:-4.20
High:15.87
Open:14.20
Low:14.05
Close:14.04
52wk High:15.87
52wk Low:4.82
Shares:138.00M
Float Shares:107.00M
Volume Ratio:3.95
T/O Rate:7.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:24.77
PE(LYR):-4.93

Loading ...

U.S. Stocks on the MOVE-Apple, Omnicom, Jersey Mike's Subs

Reuters
·
14 hours ago

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Yesterday

Compass Pathways Rises After One-Year Data for Psychedelic-Based Depression Drug

Reuters
·
Yesterday

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 Comp005 Trial Demonstrates Additional Benefit from Another Comp360 Dose in Part C Extending Durability Out to 1 Year

THOMSON REUTERS
·
Yesterday

Compass Pathways - Rolling Nda Submission Underway; Final Submission on Track for Q4

THOMSON REUTERS
·
Yesterday

Compass Pathways - Continue to Expect Commercial Launch in H1 2027

THOMSON REUTERS
·
Yesterday

Compass Pathways - Comp360 Safety Profile in Part C Consistent with Prior Parts; no New Safety Findings

THOMSON REUTERS
·
Yesterday

Compass Pathways - 25 Mg Arm Shows Average 13-Point Madrs Reduction at Week 52 with Durability to 1 Year

THOMSON REUTERS
·
Yesterday

Compass Pathways Grants Inducement Equity Awards Covering 414,100 Shares to New Hires

Reuters
·
Sep 04

Compass Pathways to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 01

Unusually active option classes on open August 26th

TIPRANKS
·
Aug 26

COMPASS Pathways (CMPS) Nears FDA Filing for COMP360 Following a Valuation Question

Simply Wall St.
·
Aug 26

Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path

TIPRANKS
·
Aug 21

How COMPASS Pathways’ VA Psilocybin Trial (CMPS) Has Reframed Its Veteran Mental Health Ambitions

Simply Wall St.
·
Aug 20

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

TIPRANKS
·
Aug 13

COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI

TIPRANKS
·
Aug 10

Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)

TIPRANKS
·
Aug 08

Compass Pathways is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 07

Compass Pathways price target raised to $22 from $17 at B. Riley

TIPRANKS
·
Aug 06

RBC Adjusts PT on COMPASS Pathways to $21 From $22, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 06